BackResponse Genetics Overview

Response Genetics Current Cash

Track Response Genetics's current cash ($1.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.73M
↓ 65.00% YoYΔ $-3.22M vs prior year quarter

Peer trimmed avg / median

Loading

Response Genetics Current Cash History

Loading

Response Genetics vs. peers: Current Cash Comparison

Loading

Response Genetics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Response Genetics (RGDXQ) FAQ

As of the most recent data (March 2015), RGDXQ shows a current cash of $1.7M. That compares with $5M in the prior-year period — down 65.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RGDXQ's current cash is now $1.7M (was $5M) — a 65.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Response Genetics is outperforming or lagging.

Tracking RGDXQ's current cash over time shows whether Response Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7M That compares with $5M in the prior-year period — down 65.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Response Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.7M) with ownership activity and broader fundamentals.